Former Lundbeck CEO: Voicing public opinions isn't always prudent

With his 70th birthday coming up Sunday: Anders Gersel Pedersen stayed for longer at Lundbeck than he had expected. He's now a professional member of the board.

Photo: Lundbeck / PR

Former Lundbeck Chief Executive Anders Gersel Pedersen, M.D., Ph.D, would like to have left as managing figure in the pharmaceutical company some time before he actually did.

Today, he's a professional member of the board with posts in, among others, biotechnology company Genmab and Bavarian Nordic. For more than a decade, however, he served as executive vice president and head of research and development at Lundbeck, a position he left in the beginning of 2019.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs